Computational KIR copy number discovery reveals interaction between inhibitory receptor burden and survival

Rachel M Pyke1, Raphael Genolet, Alexandre Harari

  • 1School of Medicine, University of California, San Diego, 9500 Gilman Dr., San Diego, CA 92093, USA, ramarty@ucsd.edu.

Insights

This study developed a new algorithm to determine killer immunoglobulin-like receptor (KIR) gene copy numbers from sequencing data. This approach reveals KIR gene variations are linked to survival in certain cancers, impacting immunotherapy.

Area of Science:

  • Immunology
  • Genetics
  • Bioinformatics

Background:

  • Natural killer (NK) cells and their killer immunoglobulin-like receptors (KIRs) are crucial for anti-tumor immunity.
  • High genetic polymorphism in KIR genes complicates genotype analysis and understanding their impact on cancer.
  • Current methods for determining KIR gene copy number are experimentally intensive.

Purpose of the Study:

  • To develop a computational algorithm for determining germline KIR gene copy number from whole exome sequencing (WES) data.
  • To apply this algorithm to a large cohort of cancer patients to investigate KIR gene variation.
  • To explore the association between KIR gene copy number variation and cancer patient survival.

Main Methods:

  • Developed a k-mer based computational algorithm to analyze WES data.
  • Quantified KIR gene sequences using k-mer distribution analysis.
  • Applied the algorithm to WES data from nearly 5000 cancer patients.

Main Results:

  • The algorithm accurately determined KIR gene copy numbers, showing high concordance with population expectations.
  • Analysis revealed an association between the burden of inhibitory KIR genes and patient survival in two cancer types.
  • This highlights the significance of KIR gene copy number variation in cancer phenotypes.

Conclusions:

  • The developed algorithm provides an efficient method for assessing KIR gene copy number from WES data.
  • KIR gene variation, specifically the burden of inhibitory KIR genes, is a significant factor in cancer survival.
  • Understanding KIR polymorphism is vital for advancing cancer immunotherapy and personalized medicine.

Related Concept Videos

Drug-Receptor Interactions01:29

Drug-Receptor Interactions

Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
7.4K
Drug-Receptor Interaction: Antagonist01:28

Drug-Receptor Interaction: Antagonist

An antagonist is a drug that binds strongly to a receptor without activating it. An antagonist prevents other molecules, such as neurotransmitters or hormones, from binding to the receptor and triggering a cellular response. Such interaction effectively hinders the normal physiological processes mediated by the receptor, resulting in various pharmacological effects depending on the specific receptor targeted.
Antagonists can be classified as competitive or noncompetitive based on their...
5.0K
Drug-Receptor Interaction: Agonist01:25

Drug-Receptor Interaction: Agonist

Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
4.0K
Quantitative Aspects of Drug-Receptor Interaction01:30

Quantitative Aspects of Drug-Receptor Interaction

The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower...
1.8K
Survival Tree01:19

Survival Tree

Survival trees are a non-parametric method used in survival analysis to model the relationship between a set of covariates and the time until an event of interest occurs, often referred to as the "time-to-event" or "survival time." This method is particularly useful when dealing with censored data, where the event has not occurred for some individuals by the end of the study period, or when the exact time of the event is unknown.
 Building a Survival Tree
Constructing a...
418
Survival Curves01:18

Survival Curves

Survival curves are graphical representations that depict the survival experience of a population over time, offering an intuitive way to track the proportion of individuals who remain event-free at each time point. These curves are widely used in fields such as medicine, public health, and reliability engineering to visualize and compare survival probabilities across different groups or conditions.
The Kaplan-Meier estimator is the most common method for constructing survival curves. This...
696